{'fraction_non_alphanumeric': 0.013050570962479609, 'fraction_numerical': 0.013050570962479609, 'mean_word_length': 5.165829145728643, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Chemosensitivity of taxol and taxol combinate for superficial bladder cancer

Objective To evaluate the use of taxol and taxol combinate in the treatment of superficial bladder cancer. Methods From July 1995 to Oct 1997, chemosensitivity of 30 superficial bladder cancer samples from different individuals and E J bladder cancer cell line was tested by taxol and taxol combinate by means of MTT assay and primary tumor cell calture. Results Total sensitive ratio of single agent, taxol is 16.7%,no difference being noted as compared with ADM or MMC while it was superior to CDDP or TT.The total sensitive rate of taxol combinate with CDDP or MMC was 83.3% and were found to be the most synergistic. Diversity of chemosensitivity was observed in samples from different individuals. Bladder cancer cell line as compared to individual bladder cancer sample has been parallel in total sensitive ratio. Conclusions Taxol combinate with CDDP or MMC can enhance the therapeufic effect in treating superficial bladder cancer.In chemotherapy of bladder cancer for different individuals the most sensitive agents should be selected.The sensitive ratio of bladder cancer cell line would not represent individual chemotherapy sensitivity.